Press Releases

April 18, 2024
Corner Therapeutics Announces $54 million Series A funding to pioneer novel vaccines that provide lifelong immunity

November 8, 2023
Corner Therapeutics Announces First Publication on Proprietary Catalytic Adjuvant Platform 

April 25, 2023
Corner Therapeutics Appoints Rick Malley, M.D., to serve on Scientific Advisory Board

November 30, 2022
Corner Therapeutics to Present Pre-Clinical Data on their Novel Dendritic Cell Hyperactivation Platform at the 4th Inflammasome Therapeutics Summit

November 10, 2022
Corner Therapeutics Debuts with Data Presentation on its Dendritic Cell Hyperactivation Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting


September 12, 2023
Targeting innate immune pathways for cancer immunotherapy

September 21, 2021
Innate immune detection of lipid oxidation as a threat assessment strategy
Nature Reviews Immunology

Scroll to Top